Overheard on Social Media: CURE Readers Discuss Survivorship Plans

This trial will assess an individualized neoantigen therapy plus Keytruda in some patients with non-small cell lung cancer.

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.

Carla Deschamps shares her experience with colon cancer and how her brother, sisters and parents helped her through the journey.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

Two colleagues of an oncology nurse highlight her utmost respect for patients and as a liaison to the greater team.

When I was diagnosed with a rare and aggressive kidney cancer, I turned to God and He has helped me through my journey, each step of the way.